Christine Iseman1, Bachir Taouli1, Rajan T. Gupta2, John Leyendecker3, Elmar Merkle2
1Mount Sinai School of Medicine, New York, NY, United States; 2Duke University, Durham, NC, United States; 3Wake Forest University, Winston-Salem, NC, United States
In this study, we report preliminary results from a US multicentric study, comparing qualitatively and quantitatively Gd-EOB-DTPA and Gd-BOPTA for diagnosis of FNH. 23 FNHs were assessed in 11 preliminary patients. Lesion conspicuity was equivalent for both contrast agents at all phases. Quantitative enhancement was significantly higher at the arterial and portal venous phases for Gd-BOPTA, and higher at the hepatobiliary phase for Gd-EOB-DTPA. These preliminary results indicate advantage for BOPTA at the dynamic phase, and advantage for EOB at the hepatobiliary phase.